117 related articles for article (PubMed ID: 2864978)
1. beta-Adrenoceptor blocking agents recognize a subpopulation of serotonin receptors in brain.
Pazos A; Engel G; Palacios JM
Brain Res; 1985 Sep; 343(2):403-8. PubMed ID: 2864978
[TBL] [Abstract][Full Text] [Related]
2. Autoradiographic characterisation and localisation of 5-HT1D compared to 5-HT1B binding sites in rat brain.
Bruinvels AT; Palacios JM; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1993 Jun; 347(6):569-82. PubMed ID: 8361548
[TBL] [Abstract][Full Text] [Related]
3. Interactions of carteolol and other beta-adrenoceptor blocking agents with serotonin receptor subtypes.
Nishio H; Nagakura Y; Segawa T
Arch Int Pharmacodyn Ther; 1989; 302():96-106. PubMed ID: 2576893
[TBL] [Abstract][Full Text] [Related]
4. Application of [125I]iodocyanopindolol to measure 5-hydroxytryptamine1B receptors in the brain of the rat.
Offord SJ; Ordway GA; Frazer A
J Pharmacol Exp Ther; 1988 Jan; 244(1):144-53. PubMed ID: 3335996
[TBL] [Abstract][Full Text] [Related]
5. Beta-adrenoceptors in the tree shrew brain. I. Distribution and characterization of [125I]iodocyanopindolol binding sites.
Flügge G; Ahrens O; Fuchs E
Cell Mol Neurobiol; 1997 Aug; 17(4):401-15. PubMed ID: 9262867
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of 125I-iodocyanopindolol binding to beta-adrenergic and serotonin-1B receptors of rat brain: selectivity of beta-adrenergic agents.
Tsuchihashi H; Nakashima Y; Kinami J; Nagatomo T
Jpn J Pharmacol; 1990 Feb; 52(2):195-200. PubMed ID: 1968985
[TBL] [Abstract][Full Text] [Related]
7. Three binding sites of 125I-iodocyanopindolol, i.e. beta 1, beta 2-adrenergic and 5HT1B-serotonergic receptors in rat brain determined by the displacement and Scatchard analysis.
Tsuchihashi H; Nagatomo T; Imai S
J Pharmacobiodyn; 1989 Sep; 12(9):509-16. PubMed ID: 2559184
[TBL] [Abstract][Full Text] [Related]
8. Serotonin depletion unmasks serotonergic component of [3H]dihydroalprenolol binding in rat brain.
Stockmeier CA; Kellar KJ
Mol Pharmacol; 1989 Dec; 36(6):903-11. PubMed ID: 2557537
[TBL] [Abstract][Full Text] [Related]
9. Characterization of 5-hydroxytryptamine1B receptors in rat spinal cord via [125I]iodocyanopindolol binding and inhibition of [3H]-5-hydroxytryptamine release.
Matsumoto I; Combs MR; Jones DJ
J Pharmacol Exp Ther; 1992 Feb; 260(2):614-26. PubMed ID: 1738111
[TBL] [Abstract][Full Text] [Related]
10. G protein dependent alterations in [125I]iodocyanopindolol and +/- cyanopindolol binding at 5-HT1B binding sites in rat brain membranes.
Ariani K; Hamblin MW; Tan GL; Stratford CA; Ciaranello RD
Neurochem Res; 1989 Sep; 14(9):835-43. PubMed ID: 2512511
[TBL] [Abstract][Full Text] [Related]
11. Beta-adrenoceptors in the tree shrew brain. II. Time-dependent effects of chronic psychosocial stress on [125I]iodocyanopindolol bindings sites.
Flügge G; Ahrens O; Fuchs E
Cell Mol Neurobiol; 1997 Aug; 17(4):417-32. PubMed ID: 9262868
[TBL] [Abstract][Full Text] [Related]
12. G-protein-linked serotonin receptors in mouse kidney exhibit identical properties to 5-HT1b receptors in brain.
Ciaranello RD; Tan GL; Dean R
J Pharmacol Exp Ther; 1990 Mar; 252(3):1347-54. PubMed ID: 2108241
[TBL] [Abstract][Full Text] [Related]
13. Labelling of rat brain beta-adrenoceptors: (3H)CGP-12177 or (125I)iodocyanopindolol?
Morin D; Zini R; Urien S; Sapena R; Tillement JP
J Recept Res; 1992; 12(3):369-87. PubMed ID: 1354747
[TBL] [Abstract][Full Text] [Related]
14. Displacement of the binding of 5-HT(1A) receptor ligands to pre- and postsynaptic receptors by (-)pindolol. A comparative study in rodent, primate and human brain.
Raurich A; Mengod G; Artigas F; Cortés R
Synapse; 1999 Oct; 34(1):68-76. PubMed ID: 10459173
[TBL] [Abstract][Full Text] [Related]
15. Determination of beta-adrenoceptor subtype on rat isolated ventricular myocytes by use of highly selective beta-antagonists.
Kitagawa Y; Adachi-Akahane S; Nagao T
Br J Pharmacol; 1995 Sep; 116(1):1635-43. PubMed ID: 8564230
[TBL] [Abstract][Full Text] [Related]
16. Ligand binding properties of putative beta 3-adrenoceptors compared in brown adipose tissue and in skeletal muscle membranes.
Sillence MN; Moore NG; Pegg GG; Lindsay DB
Br J Pharmacol; 1993 Aug; 109(4):1157-63. PubMed ID: 8104645
[TBL] [Abstract][Full Text] [Related]
17. Reconsideration of 5-hydroxytryptamine (5-HT)(7) receptor distribution using [(3)H]5-carboxamidotryptamine and [(3)H]8-hydroxy-2-(di-n-propylamino)tetraline: analysis in brain of 5-HT(1A) knockout and 5-HT(1A/1B) double-knockout mice.
Bonaventure P; Nepomuceno D; Kwok A; Chai W; Langlois X; Hen R; Stark K; Carruthers N; Lovenberg TW
J Pharmacol Exp Ther; 2002 Jul; 302(1):240-8. PubMed ID: 12065723
[TBL] [Abstract][Full Text] [Related]
18. Radioligand binding analysis of knockout mice reveals 5-hydroxytryptamine(7) receptor distribution and uncovers 8-hydroxy-2-(di-n-propylamino)tetralin interaction with alpha(2) adrenergic receptors.
Bonaventure P; Nepomuceno D; Hein L; Sutcliffe JG; Lovenberg T; Hedlund PB
Neuroscience; 2004; 124(4):901-11. PubMed ID: 15026130
[TBL] [Abstract][Full Text] [Related]
19. Specific non-beta-adrenergic binding sites for 125I-iodocyanopindolol in myocardial membrane preparations: a comparative study between human, rat, and porcine hearts.
Bjørnerheim R; Golf S; Hansson V
Cardiovasc Res; 1991 Sep; 25(9):764-73. PubMed ID: 1666020
[TBL] [Abstract][Full Text] [Related]
20. Autoradiographic mapping of 5-HT1, 5-HT1A, 5-HT1B and 5-HT2 receptors in the rat spinal cord.
Marlier L; Teilhac JR; Cerruti C; Privat A
Brain Res; 1991 May; 550(1):15-23. PubMed ID: 1832328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
